Infectious Agents and Immune System Defense Mechanisms

Infectious Agents and Human Health

Infectious agents are parasites that invade a living body, known as the host, to reproduce inside or on it, causing damage to tissues. These agents are responsible for the symptoms of various diseases. When symptoms of an illness are complex and variable among individuals, the term syndrome is used.

Types of Infectious Agents

• Viruses: Cellular parasites that require host cells to reproduce. They are the smallest infectious agents and are difficult to eliminate because they destroy the cells they inhabit. (Examples: AIDS, flu, colds, hemorrhagic fevers).
• Bacteria: Single-celled prokaryotic organisms that can reproduce independently. Elongated forms are called bacilli. (Examples: tuberculosis, anthrax, cholera).
• Protozoa and Fungi: Protozoa are unicellular eukaryotes, while fungi can be unicellular or multicellular. These are often grouped under the term parasites. (Examples: malaria, sleeping sickness, athlete's foot, candidiasis).

The Immune Response

The human body possesses natural barriers that impede the entry of infectious agents, though they are not always impenetrable. If these barriers are breached, the agents must confront the immune system. This system consists of a set of organs, tissues, and cells distributed throughout the body, with white blood cells serving as the central component. The immune response can eliminate disease-causing germs, often resolving common illnesses like colds within a few days.

Stages of Drug Development

Before a new compound is approved for medical use, it must pass through two critical stages:

1. Pre-clinical Stage

Focused on research and development, this phase verifies that the substance works as expected and is not toxic through in vitro and in vivo experiments.

2. Clinical Stage

Testing is conducted with volunteers and typically lasts from 2 to 10 years. It consists of three phases:

• Phase I: Testing is performed on small groups of healthy volunteers.
• Phase II: Tests are conducted on a small group of patients who are not receiving other treatments.
• Phase III: Testing involves a larger group of patients, comparing results against existing drugs or a placebo.